New research collaboration tackles medical challenges of space flight
Biotechnology company Vaxxinity has announced its collaboration with the University of Central Florida (UCF) to advance space medicine research.
Archives for January 22, 2024
ADHD field presents significant opportunity for global drug developers
Stimulants, amphetamines, and methylphenidates are currently the first-line treatment for moderate to severe attention-deficit/hyperactivity disorder (ADHD) across the seven major global markets; France, Germany, Italy, Spain, the UK, the US, and Japan.
Abzena launches new platforms to improve cell line efficiency
Abzena, an end-to-end CDMO for biologics and bioconjugates, has launched AbZelect and AbZelectPRO cell line development (CLD) platforms to accelerate cell lie production for manufacturing antibodies and recombinant proteins.